期刊文献+

B-藻红蛋白在表面活性剂中的光谱性质 被引量:1

Spectral characteristics of B-phycoerythrin in surfactants
下载PDF
导出
摘要 对标题化合物在3种不同类型的表面活性剂中的可见吸收光谱进行了研究。实验条件下,阳离子表面活性剂十六烷基三甲基溴化铵(CTAB)使B-藻红蛋白的最大吸收峰由545 nm蓝移至506 nm,随CTAB浓度增加,最大吸收值显著下降。阴离子表面活性剂十二烷基硫酸钠(SDS)在低浓度时对B-藻红蛋白的特征吸收峰形影响不大,当SDS的浓度>2.0×10-3mol/L时,B-PE在564 nm的吸收峰消失。非离子表面活性剂Triton X-100对B-藻红蛋白的吸收峰形没有产生明显影响,并使吸收峰强度均有所增加。还初步探讨了B-藻红蛋白在3种表面活性剂中光谱变化的机理。 The visible absorption spectra of B-phycoerythrin in three different kinds of surfactants were studied. Under experimental conditions, the hypsochromic shift made the maximum absorption peak move from 545 nm to 506 nm in the visible absorption spectra of B-phycoerythrin with cation surfactant CTAB. With an increasing CTAB concentration, the maximum absorption peak decreased remarkably. At a low concentration, the anion surfacrant SDS showed limited effect on the characteristic absorption of B-phycoerythrin, while the 564 nm characteristic absorption peak disappeared when the concentration of SDS exceeded 2.0 × 10^-3 mol/L. No obvious effect on the peak shape of B-phycoerythrin was observed by nonionic surfactant Triton X-100 and the intensity of the absorption peaks increased. The mechanism for variation of spectra of B-phycoerythrin with three different surfactants was discussed.
出处 《化学试剂》 CAS CSCD 北大核心 2009年第6期408-410,443,共4页 Chemical Reagents
基金 广东药学院博士科研启动基金项目(2006SMK01)
关键词 B-藻红蛋白 表面活性剂 光谱特性 机理 B-phycoerythrin surfactants spectra characteristic mechanism
  • 相关文献

参考文献14

  • 1SIIMAN O,WILKINSON J,BURSHTEYN A,et al.Fluorescent neoglycoproteins:antibody-aminodextran-phycobiliprotein conjugates[J].Bioconjugate Chem.,1999,10 (6):1 090-1106.
  • 2曾繁杰 杨紫萱 刘惠萍 等.条斑紫菜的藻胆蛋白研究—Ⅰ,R—藻红蛋白的物理和免疫化学性质[J].中国科学,1986,(4):364-368.
  • 3桑红.光动力疗法的应用研究现状[J].临床皮肤科杂志,2002,31(5):332-334. 被引量:35
  • 4GLAZER A N.Phycobiliproteins-a family of valuable,widely used fluorophores[J].J.Appl.Phycol.,1994,6:104-112.
  • 5TRIANTAFILOU K,TRIANTAFILOU M,WILSON K M.Phycobiliprotein-fab conjugates as probes for single particle fluorescence imaging[J].Cytometry,2000,41:226-234.
  • 6王广策,邓田,曾呈奎.藻胆蛋白的研究概况(Ⅱ)——藻胆蛋白的结构及其光谱特性[J].海洋科学,2000,24(3):19-22. 被引量:22
  • 7胡金梅,魏东,郭祀远,陈峰.一步柱层析纯化B-藻红蛋白及其毛细管电泳结合激光诱导检测[J].食品科学,2006,27(9):188-193. 被引量:5
  • 8GONCALVES P J,AGGARWAL L P F,MARQUEZIN C A,et al.Effects of interaction with CTAB micelles on photophysical characteristics of meso-tetrakis(sulfonatophenyl) porphyrin[J].J.Photochem.Photobiol.A:Chem.,2006,181:378-384.
  • 9SANTIAGO P S,MOREIRA L M,ALMEIDA E V,et al.Giant extracellular glossoscolex paulistus hemoglobin(HbGp) interaction with cethyltrimethylammo-nium chloride (CTAC) and sodium dodeeyl sulphate (SDS) surfactants:dissociation of oligomeric structure and autoxidation[J].Biochim.Biophys.Acts,2007,1 770:506-517.
  • 10TURRO N J,ANANTHAPADMANABIIAN K P,LEI Xuegong,et al.Spectroscopic probe analysis of protein-surfactant interaction in the BSA/SDS system[J].Langmuir,1995,11:2 525-2 533.

二级参考文献43

  • 1刘石生,魏东,朱桂芳,王一飞,李琳.紫球藻胞外多糖抗柯萨奇B_3病毒活性[J].华南理工大学学报(自然科学版),2005,33(2):82-85. 被引量:7
  • 2张成武,殷志敏,欧阳平凯.藻胆蛋白的开发与利用[J].中国海洋药物,1995,14(3):52-53. 被引量:44
  • 3[1]Ceburkov O, Gollnick H. Photodynamic therapy in dermatology[J].Eur J Dermatol, 2000, 10(7): 568-576.
  • 4[2]Lange N, Jichlinski P, Zellweger M, et 1. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study[J] . Br J Cancer, 1999, 80(1-2): 185-193.
  • 5[3]Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology[J]. Arch Dermatol, 2000, 10: 568-576.
  • 6[4]Bunke A, Zerbe O, Schmid H, et al. Degradation mechanism and stability of 5-aminolevulinic acid[J] . J Pharm Sci, 2000, 89(10):1335-1341.
  • 7[5]Soler AM, Warloe T, Tausjo, J, et al. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid[J] . Acta Oncol, 2000, 39(5): 605-609.
  • 8[6]Szeimies RM, Karrer S, Sauerwald A, et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study[J]. Dermatology, 1996, 192 (3)246-251.
  • 9[7]Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses[J] . J Am Acad Dermatol, 1999, 41 (3Ptl): 414-418.
  • 10[8]Salim A, Whitehurst C, Morton CA. Comparison of photodynamic therapy with cryotherapy in the treatmen of Bowen' s disease[J]. Br J of Dermatol, 2000, 114(Suppl. 57): 114.

共引文献72

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部